Related Experiment Video
Updated: May 17, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Progress towards identifying biomarkers of vascular aging for total cardiovascular risk prediction
1Peripheral Vessels Unit, 1st Department of Cardiology, Athens Medical School, Hippokration Hospital, Athens, Greece. cvlachop@otenet.gr
Insights
Vascular aging biomarkers, like arterial stiffness, show promise for predicting cardiovascular risk beyond traditional factors. Arterial stiffness meets clinical criteria, while endothelial function has limitations for risk prediction.
Area of Science:
- Cardiovascular Medicine
- Biomarker Research
- Vascular Biology
Background:
- Traditional cardiovascular risk scores have limitations in predicting actual events.
- Vascular aging, reflecting cumulative risk factor impact on arteries, offers a potential measure of overall cardiovascular risk.
- Integrating new biomarkers requires validation for calibration, discrimination, and reclassification.
Purpose of the Study:
- To evaluate candidate arterial biomarkers for their potential to gauge cardiovascular risk.
- To assess if arterial biomarkers provide incremental predictive value over traditional risk factors.
- To determine which arterial biomarkers meet stringent criteria for clinical practice integration.
Main Methods:
- Review of current evidence on arterial stiffness, central hemodynamics, carotid intima-media thickness, and endothelial function.
- Assessment of biomarkers against criteria for calibration, discrimination, and reclassification.
- Comparison of predictive value against established cardiovascular risk factors.
Main Results:
- Arterial stiffness demonstrates fulfillment of criteria for a vascular aging biomarker.
- Central hemodynamics and carotid intima-media thickness are considered close contenders.
- Endothelial function exhibits methodological limitations impacting its risk prediction utility.
Conclusions:
- Arterial stiffness is a validated biomarker for vascular aging and cardiovascular risk assessment.
- Central hemodynamics and carotid intima-media thickness warrant further investigation for clinical application.
- Endothelial function, due to methodological variability, is less suitable for routine cardiovascular risk prediction.
Abstract:
Although several scoring systems for cardiovascular risk prediction are valuable in the assessment and management of asymptomatic individuals and patients, differences between predicted and actual events do exist. The concept of vascular aging as a cumulative measure of the impact of cardiovascular risk factors on the arterial wall has the potential to gauge an individual's overall cardiovascular risk. In this context, candidate arterial biomarkers, apart from proving an incremental predictive value over and above traditional risk factors, must fulfill stringent criteria in order to be integrated into clinical practice; these include calibration, discrimination and reclassification. Current evidence suggests that arterial stiffness fulfills the criteria for a biomarker of vascular aging, whereas central hemodynamics and carotid intima-media thickness are close. Endothelial function, although a valuable research tool, has shortcomings in terms of risk prediction, largely dependent on the methodological approach, which may make it less desirable as a biomarker.
More Related Videos
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
09:33A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction